Academician Hou Huimin Workstation

        Hou Huimin academician workstation is the director of the National Engineering Research Center for Pharmaceutical Preparations, Chinese Academy of Engineering Hou Huimin led the establishment of the first enterprise academician workstation. Academician workstation is located in Jiangsu Shuanglin Marine Biological Pharmaceutical Co.

      National Engineering Research Center for Pharmaceutical Preparations is a national pharmaceutical preparations research and development institution invested by the State Planning Commission, the former State Administration of Medicine and the Shanghai Academy of Pharmaceutical Sciences. There are 44 academicians in the National Engineering Research Center of Pharmaceutical Preparations, 15 technicians in the team of academician Huimin Hou, including 1 academician of the Chinese Academy of Engineering, 10 senior titles, 9 masters, engaged in the development of new drug preparations and chitin drug excipients industrial production of key technology research. It has 22 authorized invention patents and 18 invention patents under application.

      Under the leadership of academician Huimin Hou, director of the center, a group of PhDs, masters and senior researchers are working hard on the research and development of highly efficient, slow-release, controlled-release, targeted and transdermal drug preparations of Chinese and Western medicines. The scientific and technological achievements are also being engineered to achieve industrialization of complete sets of technologies.

The establishment of Academician Hou Huimin's workstation has greatly enhanced the enterprise's innovation and scientific research capability:

      1, the research and development of chitin pharmaceutical excipients, for China's chitin drug excipients industrialized production to create a technical platform to fill the gaps in China's chitin pharmaceutical excipients;

      2、Through the strong scientific research team, we can research, develop and produce specific molecular weight chitosan, and develop new drugs for the treatment of arteriosclerosis;

      3、Through the cooperation with the academician team, we can train and cultivate a group of chitin pharmaceutical excipients talents for Shuanglin Group, and improve the technical level of our technicians in R&D, testing and other aspects.

      4、Establish the technical standard of chitin pharmaceutical excipients and related derivative drugs;

      5、Promote the research and development speed and industrialization of chitin biologics, and strive to catch up with the world's first-class level.